AI Changing The Skills Balance In Pharmacovigilance Teams
In the second segment of a two-part article on the use of artificial intelligence in pharmacovigilance, a senior UK regulator and representatives from the pharmaceutical industry discuss new skills that drug safety professionals must acquire as companies increasingly embrace AI tools.
You may also be interested in...
In the first of a two-part series of articles on the use of artificial intelligence in pharmacovigilance, the Pink Sheet reports on what factors the UK medicines inspectors consider crucial to demonstrate the effectiveness of such AI systems. The second article will discuss how the balance between the use of AI and human resources is likely to change over time.
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.